摘要
目的对慢性阻塞性肺疾病加重期合并有肺栓塞易栓因素的患者使用注射低分子肝素钠治疗,观察患者肺功能以及症状的改善情况。方法对60例慢性阻塞性肺疾病患者随机分为观察组和对照组,对2组病人治疗前,治疗后红细泡比容和动脉血气分析的变化进行对照,观察2组病人症状的改善。结果治疗组与对照组患者在红细胞比容、动脉血气分析、症状改善情况存在显著性差异(P<0.05)。结论对慢性阻塞性肺疾病加重期合并有肺栓塞易栓因素的患者使用注射低分子肝素钠治疗,可以改善患者的肺功能及减轻临床症状,对预防肺栓塞起到积极作用。
Objective chronic obstructive pulmonary disease exacerbation associated with pulmonary embolism in patients with thrombophilic risk factors of low molecular weight heparin injection were observed in patients with lung function and symptoms improvement.Methods 60 patients with chronic obstructive pulmonary disease were randomly divided into two groups and the control group,the two groups before treatment,after treatment,hematocrit and red fine bubble changes in arterial blood gas analysis,control,symptom improvement were observed.Results The treatment group and control group patients hematocrit,arterial blood gas analysis,there were significant improvements in symptoms difference （P〈0.05）.Conclusion Chronic Obstructive Pulmonary Disease Exacerbation of thrombophilic risk factors associated with pulmonary embolism in patients using the injection of low molecular weight heparin therapy can improve lung function and reduce the clinical symptoms,play an active role in the prevention of pulmonary embolism.
出处
《中外医疗》
2010年第21期29-30,共2页
China & Foreign Medical Treatment
关键词
低分子肝素钠
慢性阻塞性肺疾病
作用探讨
Low molecular weight heparin
Chronic obstructive pulmonary disease
Role of
